Swiss Re stock holds 2026 target after 9M profit rises 3%
Published on 11/10/2026 at 11:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSwiss Re strengthens earnings outlook
- Swiss Re kept its 2026 net income target after strong contributions from all three business units.
- Competitive property and casualty pricing reduced new-business margins and P&C earnings.
- Corporate Solutions is expanding its commercial platform while preparing a new global leadership role.
- The next financial target update is scheduled for December 4, 2026.
Swiss Re reported a 3% increase in net income for the first nine months of 2026 in a press release published on November 5. Net income reached USD 4.2 billion, while annualised return on equity remained at 22.5%. Management kept its full-year 2026 net income target at USD 4.5 billion.
Swiss Re stock traded at 164.00 euros on Lang & Schwarz at 11:04 CET on Tuesday, November 10, 2026.
Three businesses support the target
The result benefited from contributions across all three business units, lower-than-expected large natural catastrophe losses and solid investment income. The insurance service result rose to USD 5.1 billion from USD 4.8 billion in the prior-year period, while insurance revenue declined to USD 31.2 billion from USD 32.0 billion.
Life & Health Re delivered the strongest earnings growth, with net income rising to USD 1.5 billion from USD 1.1 billion. Swiss Re attributed the performance to its large in-force portfolio and favourable US mortality experience. The unit is targeting USD 1.7 billion in net income for the full year.
Property & Casualty Re recorded net income of USD 2.2 billion, down from USD 2.3 billion. Its combined ratio improved slightly to 77.3% from 77.6%, remaining inside the full-year target of less than 85%. Swiss Re said competitive market conditions affected earnings, insurance revenue and new-business profitability.
Pricing pressure shapes new business
Group new-business contractual service margin fell to USD 2.8 billion from USD 3.9 billion. Swiss Re linked the decline to a competitive P&C renewals environment, lower volumes in parts of Life & Health Re and a more selective approach to new business.
Chief Financial Officer Anders Malmstrom said current earnings reflected disciplined underwriting and portfolio management, while lower margins on new business showed the effect of competitive P&C pricing. Chief Executive Officer Andreas Berger said the group was combining underwriting discipline, cost efficiency and selective commercial expansion as market conditions changed.
Swiss Re is targeting USD 500 million of operating-cost reductions by 2028. The company also said its estimated Group Swiss Solvency Test ratio stood at 259% on October 1, above its target range of 200% to 250%, subject to review.
Corporate Solutions adds commercial capacity
Corporate Solutions increased net income to USD 714 million from USD 693 million. Its insurance service result rose to USD 863 million from USD 832 million, while the combined ratio improved to 86.4% from 87.1%. The unit's full-year target is below 91%.
Swiss Re also announced that Lori Goltermann will become Chief Commercial Officer for Corporate Solutions on January 11, 2027. In the newly created role, she will lead the enterprise-wide strategy for corporate clients, governments and distribution partners and report to Corporate Solutions Chief Executive Ivan Gonzalez.
The company is centralising its global underwriting function while giving market units greater responsibility for client engagement, growth opportunities and new business origination. It also announced a strategic cooperation with Old Mutual Insure in South Africa, subject to regulatory approval.
Swiss Re AG
- ISIN: CH0126881561
- WKN: A1H81M
- Xetra symbol: SR9
- Lang & Schwarz price: 164.00 euros at 11:04 CET on November 10, 2026
The Swiss market backdrop is covered in Current market reports.
Swiss Re's next scheduled financial target update is on December 4, 2026, followed by its 2026 annual results on February 26, 2027. More news and analyses on Swiss Re stock.
